nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—jaw skeleton—head and neck cancer	0.151	0.428	CbGeAlD
Ibandronate—FDPS—hair follicle—head and neck cancer	0.0414	0.117	CbGeAlD
Ibandronate—FDPS—mouth—head and neck cancer	0.0325	0.0918	CbGeAlD
Ibandronate—FDPS—parotid gland—head and neck cancer	0.0226	0.0639	CbGeAlD
Ibandronate—FDPS—saliva-secreting gland—head and neck cancer	0.0217	0.0612	CbGeAlD
Ibandronate—FDPS—connective tissue—head and neck cancer	0.0199	0.0563	CbGeAlD
Ibandronate—FDPS—trachea—head and neck cancer	0.0167	0.0472	CbGeAlD
Ibandronate—FDPS—lymphoid tissue—head and neck cancer	0.0146	0.0411	CbGeAlD
Ibandronate—FDPS—thyroid gland—head and neck cancer	0.0132	0.0374	CbGeAlD
Ibandronate—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.0126	0.0199	CcSEcCtD
Ibandronate—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.0124	0.0194	CcSEcCtD
Ibandronate—FDPS—head—head and neck cancer	0.0117	0.0332	CbGeAlD
Ibandronate—Local reaction—Fluorouracil—head and neck cancer	0.0102	0.016	CcSEcCtD
Ibandronate—Risedronate—PTGS2—head and neck cancer	0.00998	1	CrCbGaD
Ibandronate—Rash generalised—Docetaxel—head and neck cancer	0.00959	0.0151	CcSEcCtD
Ibandronate—Bone pain—Vinblastine—head and neck cancer	0.00898	0.0141	CcSEcCtD
Ibandronate—Prurigo—Docetaxel—head and neck cancer	0.00883	0.0139	CcSEcCtD
Ibandronate—Duodenal ulcer—Docetaxel—head and neck cancer	0.00844	0.0133	CcSEcCtD
Ibandronate—Ulcer—Hydroxyurea—head and neck cancer	0.0083	0.013	CcSEcCtD
Ibandronate—Creatinine increased—Hydroxyurea—head and neck cancer	0.00824	0.013	CcSEcCtD
Ibandronate—FDPS—lymph node—head and neck cancer	0.00822	0.0232	CbGeAlD
Ibandronate—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00703	0.0111	CcSEcCtD
Ibandronate—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00699	0.011	CcSEcCtD
Ibandronate—Deafness—Vinblastine—head and neck cancer	0.00698	0.011	CcSEcCtD
Ibandronate—Oral candidiasis—Docetaxel—head and neck cancer	0.00642	0.0101	CcSEcCtD
Ibandronate—Parosmia—Docetaxel—head and neck cancer	0.00629	0.00989	CcSEcCtD
Ibandronate—Renal failure acute—Hydroxyurea—head and neck cancer	0.00617	0.0097	CcSEcCtD
Ibandronate—Redness—Docetaxel—head and neck cancer	0.00604	0.0095	CcSEcCtD
Ibandronate—Ulcer—Fluorouracil—head and neck cancer	0.00597	0.00939	CcSEcCtD
Ibandronate—Neuralgia—Docetaxel—head and neck cancer	0.00587	0.00923	CcSEcCtD
Ibandronate—Inflammation—Fluorouracil—head and neck cancer	0.00582	0.00916	CcSEcCtD
Ibandronate—Throat sore—Docetaxel—head and neck cancer	0.00566	0.0089	CcSEcCtD
Ibandronate—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00561	0.00882	CcSEcCtD
Ibandronate—Dermatitis atopic—Docetaxel—head and neck cancer	0.00551	0.00866	CcSEcCtD
Ibandronate—Face oedema—Hydroxyurea—head and neck cancer	0.0055	0.00865	CcSEcCtD
Ibandronate—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00534	0.00839	CcSEcCtD
Ibandronate—Rash erythematous—Docetaxel—head and neck cancer	0.00532	0.00837	CcSEcCtD
Ibandronate—Oesophagitis—Fluorouracil—head and neck cancer	0.00516	0.00812	CcSEcCtD
Ibandronate—Breast disorder—Hydroxyurea—head and neck cancer	0.00515	0.0081	CcSEcCtD
Ibandronate—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00507	0.00798	CcSEcCtD
Ibandronate—Rigors—Docetaxel—head and neck cancer	0.00499	0.00785	CcSEcCtD
Ibandronate—Depression—Vinblastine—head and neck cancer	0.0048	0.00755	CcSEcCtD
Ibandronate—Swelling—Fluorouracil—head and neck cancer	0.00465	0.00731	CcSEcCtD
Ibandronate—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00448	0.00705	CcSEcCtD
Ibandronate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00439	0.0069	CcSEcCtD
Ibandronate—Infestation—Hydroxyurea—head and neck cancer	0.00439	0.0069	CcSEcCtD
Ibandronate—Amnesia—Fluorouracil—head and neck cancer	0.00436	0.00686	CcSEcCtD
Ibandronate—Haemoglobin—Vinblastine—head and neck cancer	0.00434	0.00683	CcSEcCtD
Ibandronate—Haemorrhage—Vinblastine—head and neck cancer	0.00432	0.0068	CcSEcCtD
Ibandronate—Pharyngitis—Vinblastine—head and neck cancer	0.00429	0.00675	CcSEcCtD
Ibandronate—Stomatitis—Hydroxyurea—head and neck cancer	0.00428	0.00673	CcSEcCtD
Ibandronate—Bone pain—Docetaxel—head and neck cancer	0.00426	0.00669	CcSEcCtD
Ibandronate—Inflammation—Docetaxel—head and neck cancer	0.0042	0.00661	CcSEcCtD
Ibandronate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00415	0.00653	CcSEcCtD
Ibandronate—Osteoarthritis—Fluorouracil—head and neck cancer	0.0041	0.00645	CcSEcCtD
Ibandronate—Injection site reaction—Docetaxel—head and neck cancer	0.00405	0.00637	CcSEcCtD
Ibandronate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00396	0.00623	CcSEcCtD
Ibandronate—Influenza like illness—Docetaxel—head and neck cancer	0.00396	0.00623	CcSEcCtD
Ibandronate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00394	0.0062	CcSEcCtD
Ibandronate—Candida infection—Docetaxel—head and neck cancer	0.00389	0.00612	CcSEcCtD
Ibandronate—Alopecia—Vinblastine—head and neck cancer	0.00382	0.00601	CcSEcCtD
Ibandronate—Oesophagitis—Docetaxel—head and neck cancer	0.00373	0.00586	CcSEcCtD
Ibandronate—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00367	0.00577	CcSEcCtD
Ibandronate—Pulmonary oedema—Docetaxel—head and neck cancer	0.00363	0.00571	CcSEcCtD
Ibandronate—Angiopathy—Hydroxyurea—head and neck cancer	0.00358	0.00562	CcSEcCtD
Ibandronate—Dysphagia—Fluorouracil—head and neck cancer	0.00354	0.00557	CcSEcCtD
Ibandronate—Chills—Hydroxyurea—head and neck cancer	0.00354	0.00556	CcSEcCtD
Ibandronate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00349	0.00549	CcSEcCtD
Ibandronate—Alopecia—Hydroxyurea—head and neck cancer	0.00348	0.00548	CcSEcCtD
Ibandronate—Anaemia—Vinblastine—head and neck cancer	0.00348	0.00547	CcSEcCtD
Ibandronate—Erythema—Hydroxyurea—head and neck cancer	0.00343	0.0054	CcSEcCtD
Ibandronate—Malaise—Vinblastine—head and neck cancer	0.00339	0.00534	CcSEcCtD
Ibandronate—Vertigo—Vinblastine—head and neck cancer	0.00338	0.00532	CcSEcCtD
Ibandronate—Swelling—Docetaxel—head and neck cancer	0.00335	0.00528	CcSEcCtD
Ibandronate—Deafness—Docetaxel—head and neck cancer	0.00331	0.0052	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00329	0.00518	CcSEcCtD
Ibandronate—Hypertension—Vinblastine—head and neck cancer	0.00325	0.00511	CcSEcCtD
Ibandronate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00318	0.00501	CcSEcCtD
Ibandronate—Pneumonia—Fluorouracil—head and neck cancer	0.00318	0.005	CcSEcCtD
Ibandronate—Anaemia—Hydroxyurea—head and neck cancer	0.00317	0.00499	CcSEcCtD
Ibandronate—Discomfort—Vinblastine—head and neck cancer	0.00316	0.00498	CcSEcCtD
Ibandronate—Infestation NOS—Fluorouracil—head and neck cancer	0.00316	0.00497	CcSEcCtD
Ibandronate—Infestation—Fluorouracil—head and neck cancer	0.00316	0.00497	CcSEcCtD
Ibandronate—Renal impairment—Docetaxel—head and neck cancer	0.00311	0.00489	CcSEcCtD
Ibandronate—Malaise—Hydroxyurea—head and neck cancer	0.00309	0.00487	CcSEcCtD
Ibandronate—Stomatitis—Fluorouracil—head and neck cancer	0.00308	0.00484	CcSEcCtD
Ibandronate—Urinary tract infection—Fluorouracil—head and neck cancer	0.00307	0.00483	CcSEcCtD
Ibandronate—Pain in extremity—Docetaxel—head and neck cancer	0.00296	0.00465	CcSEcCtD
Ibandronate—Migraine—Docetaxel—head and neck cancer	0.00291	0.00458	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0029	0.00456	CcSEcCtD
Ibandronate—Discomfort—Hydroxyurea—head and neck cancer	0.00289	0.00454	CcSEcCtD
Ibandronate—Haemoglobin—Fluorouracil—head and neck cancer	0.00285	0.00448	CcSEcCtD
Ibandronate—Haemorrhage—Fluorouracil—head and neck cancer	0.00284	0.00446	CcSEcCtD
Ibandronate—Pharyngitis—Fluorouracil—head and neck cancer	0.00282	0.00443	CcSEcCtD
Ibandronate—Infection—Hydroxyurea—head and neck cancer	0.00278	0.00437	CcSEcCtD
Ibandronate—Paraesthesia—Vinblastine—head and neck cancer	0.00276	0.00434	CcSEcCtD
Ibandronate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00275	0.00432	CcSEcCtD
Ibandronate—Skin disorder—Hydroxyurea—head and neck cancer	0.00272	0.00428	CcSEcCtD
Ibandronate—Abdominal pain upper—Docetaxel—head and neck cancer	0.0027	0.00425	CcSEcCtD
Ibandronate—Breast disorder—Docetaxel—head and neck cancer	0.00267	0.00421	CcSEcCtD
Ibandronate—Decreased appetite—Vinblastine—head and neck cancer	0.00267	0.0042	CcSEcCtD
Ibandronate—Cramp muscle—Docetaxel—head and neck cancer	0.00267	0.00419	CcSEcCtD
Ibandronate—Nasopharyngitis—Docetaxel—head and neck cancer	0.00265	0.00416	CcSEcCtD
Ibandronate—Constipation—Vinblastine—head and neck cancer	0.00263	0.00413	CcSEcCtD
Ibandronate—Pain—Vinblastine—head and neck cancer	0.00263	0.00413	CcSEcCtD
Ibandronate—Dysphagia—Docetaxel—head and neck cancer	0.00256	0.00402	CcSEcCtD
Ibandronate—Feeling abnormal—Vinblastine—head and neck cancer	0.00253	0.00398	CcSEcCtD
Ibandronate—Bronchospasm—Docetaxel—head and neck cancer	0.00252	0.00396	CcSEcCtD
Ibandronate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00251	0.00395	CcSEcCtD
Ibandronate—Alopecia—Fluorouracil—head and neck cancer	0.00251	0.00394	CcSEcCtD
Ibandronate—Erythema—Fluorouracil—head and neck cancer	0.00247	0.00388	CcSEcCtD
Ibandronate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00246	0.00388	CcSEcCtD
Ibandronate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00243	0.00383	CcSEcCtD
Ibandronate—Abdominal pain—Vinblastine—head and neck cancer	0.00243	0.00382	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00242	0.0038	CcSEcCtD
Ibandronate—Fatigue—Hydroxyurea—head and neck cancer	0.00241	0.0038	CcSEcCtD
Ibandronate—Pain—Hydroxyurea—head and neck cancer	0.00239	0.00377	CcSEcCtD
Ibandronate—Constipation—Hydroxyurea—head and neck cancer	0.00239	0.00377	CcSEcCtD
Ibandronate—Weight decreased—Docetaxel—head and neck cancer	0.00231	0.00364	CcSEcCtD
Ibandronate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00231	0.00363	CcSEcCtD
Ibandronate—Pneumonia—Docetaxel—head and neck cancer	0.00229	0.00361	CcSEcCtD
Ibandronate—Anaemia—Fluorouracil—head and neck cancer	0.00228	0.00359	CcSEcCtD
Ibandronate—Infestation NOS—Docetaxel—head and neck cancer	0.00228	0.00359	CcSEcCtD
Ibandronate—Infestation—Docetaxel—head and neck cancer	0.00228	0.00359	CcSEcCtD
Ibandronate—Hypersensitivity—Vinblastine—head and neck cancer	0.00226	0.00356	CcSEcCtD
Ibandronate—Renal failure—Docetaxel—head and neck cancer	0.00224	0.00353	CcSEcCtD
Ibandronate—Stomatitis—Docetaxel—head and neck cancer	0.00222	0.0035	CcSEcCtD
Ibandronate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00221	0.00348	CcSEcCtD
Ibandronate—Asthenia—Vinblastine—head and neck cancer	0.0022	0.00346	CcSEcCtD
Ibandronate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00216	0.00339	CcSEcCtD
Ibandronate—Chest pain—Fluorouracil—head and neck cancer	0.0021	0.00331	CcSEcCtD
Ibandronate—Myalgia—Fluorouracil—head and neck cancer	0.0021	0.00331	CcSEcCtD
Ibandronate—Diarrhoea—Vinblastine—head and neck cancer	0.0021	0.0033	CcSEcCtD
Ibandronate—Discomfort—Fluorouracil—head and neck cancer	0.00208	0.00327	CcSEcCtD
Ibandronate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00206	0.00324	CcSEcCtD
Ibandronate—Haemoglobin—Docetaxel—head and neck cancer	0.00206	0.00324	CcSEcCtD
Ibandronate—Haemorrhage—Docetaxel—head and neck cancer	0.00205	0.00322	CcSEcCtD
Ibandronate—Pharyngitis—Docetaxel—head and neck cancer	0.00203	0.0032	CcSEcCtD
Ibandronate—Dizziness—Vinblastine—head and neck cancer	0.00203	0.00319	CcSEcCtD
Ibandronate—Urinary tract disorder—Docetaxel—head and neck cancer	0.00202	0.00318	CcSEcCtD
Ibandronate—Oedema peripheral—Docetaxel—head and neck cancer	0.00202	0.00317	CcSEcCtD
Ibandronate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00202	0.00317	CcSEcCtD
Ibandronate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00201	0.00316	CcSEcCtD
Ibandronate—Asthenia—Hydroxyurea—head and neck cancer	0.00201	0.00316	CcSEcCtD
Ibandronate—Urethral disorder—Docetaxel—head and neck cancer	0.00201	0.00316	CcSEcCtD
Ibandronate—Infection—Fluorouracil—head and neck cancer	0.002	0.00315	CcSEcCtD
Ibandronate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00198	0.00311	CcSEcCtD
Ibandronate—Vomiting—Vinblastine—head and neck cancer	0.00195	0.00307	CcSEcCtD
Ibandronate—Headache—Vinblastine—head and neck cancer	0.00192	0.00303	CcSEcCtD
Ibandronate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00192	0.00301	CcSEcCtD
Ibandronate—Eye disorder—Docetaxel—head and neck cancer	0.00191	0.00301	CcSEcCtD
Ibandronate—Cardiac disorder—Docetaxel—head and neck cancer	0.0019	0.00299	CcSEcCtD
Ibandronate—Angiopathy—Docetaxel—head and neck cancer	0.00186	0.00292	CcSEcCtD
Ibandronate—Dizziness—Hydroxyurea—head and neck cancer	0.00185	0.00291	CcSEcCtD
Ibandronate—Immune system disorder—Docetaxel—head and neck cancer	0.00185	0.00291	CcSEcCtD
Ibandronate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00185	0.0029	CcSEcCtD
Ibandronate—Chills—Docetaxel—head and neck cancer	0.00184	0.00289	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00184	0.00289	CcSEcCtD
Ibandronate—Nausea—Vinblastine—head and neck cancer	0.00182	0.00287	CcSEcCtD
Ibandronate—Insomnia—Fluorouracil—head and neck cancer	0.00182	0.00287	CcSEcCtD
Ibandronate—Paraesthesia—Fluorouracil—head and neck cancer	0.00181	0.00285	CcSEcCtD
Ibandronate—Alopecia—Docetaxel—head and neck cancer	0.00181	0.00285	CcSEcCtD
Ibandronate—Mental disorder—Docetaxel—head and neck cancer	0.00179	0.00282	CcSEcCtD
Ibandronate—Malnutrition—Docetaxel—head and neck cancer	0.00178	0.0028	CcSEcCtD
Ibandronate—Erythema—Docetaxel—head and neck cancer	0.00178	0.0028	CcSEcCtD
Ibandronate—Vomiting—Hydroxyurea—head and neck cancer	0.00178	0.0028	CcSEcCtD
Ibandronate—Dyspepsia—Fluorouracil—head and neck cancer	0.00177	0.00279	CcSEcCtD
Ibandronate—Rash—Hydroxyurea—head and neck cancer	0.00177	0.00278	CcSEcCtD
Ibandronate—Dermatitis—Hydroxyurea—head and neck cancer	0.00176	0.00277	CcSEcCtD
Ibandronate—Headache—Hydroxyurea—head and neck cancer	0.00175	0.00276	CcSEcCtD
Ibandronate—Decreased appetite—Fluorouracil—head and neck cancer	0.00175	0.00276	CcSEcCtD
Ibandronate—Dysgeusia—Docetaxel—head and neck cancer	0.00175	0.00275	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00174	0.00274	CcSEcCtD
Ibandronate—Back pain—Docetaxel—head and neck cancer	0.00172	0.00271	CcSEcCtD
Ibandronate—Pain—Fluorouracil—head and neck cancer	0.00172	0.00271	CcSEcCtD
Ibandronate—Muscle spasms—Docetaxel—head and neck cancer	0.00171	0.0027	CcSEcCtD
Ibandronate—Nausea—Hydroxyurea—head and neck cancer	0.00166	0.00262	CcSEcCtD
Ibandronate—Feeling abnormal—Fluorouracil—head and neck cancer	0.00166	0.00261	CcSEcCtD
Ibandronate—Anaemia—Docetaxel—head and neck cancer	0.00165	0.00259	CcSEcCtD
Ibandronate—Urticaria—Fluorouracil—head and neck cancer	0.0016	0.00252	CcSEcCtD
Ibandronate—Body temperature increased—Fluorouracil—head and neck cancer	0.00159	0.00251	CcSEcCtD
Ibandronate—Palpitations—Docetaxel—head and neck cancer	0.00158	0.00248	CcSEcCtD
Ibandronate—Hypertension—Docetaxel—head and neck cancer	0.00154	0.00242	CcSEcCtD
Ibandronate—Myalgia—Docetaxel—head and neck cancer	0.00152	0.00239	CcSEcCtD
Ibandronate—Chest pain—Docetaxel—head and neck cancer	0.00152	0.00239	CcSEcCtD
Ibandronate—Arthralgia—Docetaxel—head and neck cancer	0.00152	0.00239	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00151	0.00237	CcSEcCtD
Ibandronate—Hypersensitivity—Fluorouracil—head and neck cancer	0.00148	0.00234	CcSEcCtD
Ibandronate—Dry mouth—Docetaxel—head and neck cancer	0.00148	0.00233	CcSEcCtD
Ibandronate—Anaphylactic shock—Docetaxel—head and neck cancer	0.00145	0.00229	CcSEcCtD
Ibandronate—Infection—Docetaxel—head and neck cancer	0.00145	0.00227	CcSEcCtD
Ibandronate—Shock—Docetaxel—head and neck cancer	0.00143	0.00225	CcSEcCtD
Ibandronate—Nervous system disorder—Docetaxel—head and neck cancer	0.00143	0.00224	CcSEcCtD
Ibandronate—Pruritus—Fluorouracil—head and neck cancer	0.00143	0.00224	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—head and neck cancer	0.00141	0.00222	CcSEcCtD
Ibandronate—Diarrhoea—Fluorouracil—head and neck cancer	0.00138	0.00217	CcSEcCtD
Ibandronate—Dizziness—Fluorouracil—head and neck cancer	0.00133	0.0021	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00133	0.00208	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—head and neck cancer	0.00132	0.00207	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—head and neck cancer	0.00131	0.00205	CcSEcCtD
Ibandronate—Vomiting—Fluorouracil—head and neck cancer	0.00128	0.00202	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—head and neck cancer	0.00128	0.00201	CcSEcCtD
Ibandronate—Rash—Fluorouracil—head and neck cancer	0.00127	0.002	CcSEcCtD
Ibandronate—Dermatitis—Fluorouracil—head and neck cancer	0.00127	0.002	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—head and neck cancer	0.00126	0.00199	CcSEcCtD
Ibandronate—Headache—Fluorouracil—head and neck cancer	0.00126	0.00199	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00126	0.00198	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—head and neck cancer	0.00125	0.00197	CcSEcCtD
Ibandronate—Pain—Docetaxel—head and neck cancer	0.00124	0.00196	CcSEcCtD
Ibandronate—Constipation—Docetaxel—head and neck cancer	0.00124	0.00196	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—head and neck cancer	0.0012	0.00189	CcSEcCtD
Ibandronate—Nausea—Fluorouracil—head and neck cancer	0.0012	0.00188	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00119	0.00187	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—head and neck cancer	0.00115	0.00181	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—head and neck cancer	0.00115	0.00181	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—head and neck cancer	0.00107	0.00169	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—head and neck cancer	0.00104	0.00164	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—head and neck cancer	0.00103	0.00162	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—head and neck cancer	0.000995	0.00157	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—head and neck cancer	0.000962	0.00151	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—head and neck cancer	0.000925	0.00145	CcSEcCtD
Ibandronate—Rash—Docetaxel—head and neck cancer	0.000917	0.00144	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—head and neck cancer	0.000916	0.00144	CcSEcCtD
Ibandronate—Headache—Docetaxel—head and neck cancer	0.000911	0.00143	CcSEcCtD
Ibandronate—Nausea—Docetaxel—head and neck cancer	0.000864	0.00136	CcSEcCtD
